Prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa - 09/12/21
Abstract |
Background |
Information on prevalence of depression among children, adolescents, and adults with hidradenitis suppurativa (HS) is limited.
Objective |
To compare prevalence of depression in HS patients with that of controls.
Methods |
Cross-sectional analysis of 38,140 adult and 1162 pediatric HS patients and controls identified using data from electronic health records. Primary outcome was prevalent depression.
Results |
Prevalence of depression among adults with HS was 30.0% (95% Confidence interval [CI], 29.6-30.5), compared with 16.9% (95% CI, 16.7-17.1) among controls. Among children and adolescents with HS, prevalence of depression was 11.7% (95% CI, 10.0-13.7), compared with 4.1% (95% CI, 3.6-4.7) among controls. In adjusted analyses, adults and children/adolescents with HS had 1.26 (95% CI, 1.25-1.28; P < .001) and 1.42 (95% CI, 0.999-2.01; P = .051) times the odds of having depression relative to controls, respectively.
Limitations |
We could not evaluate the influence of disease severity on the outcome.
Conclusion |
Depression is prevalent among children, adolescents, and adults with HS. Periodic screening for depression may be warranted.
Le texte complet de cet article est disponible en PDF.Keywords : hidradenitis suppurativa, depression, mood, adults, children, adolescents, prevalence, Explorys
Abbreviations used : CI, HS, ICD, OR
Plan
Funding sources: Supported in part by an education grant from AbbVie. AbbVie had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. |
|
IRB approval status: Approved by the human subjects committee at the Feinstein Institutes for Medical Research at Northwell Health. |
|
Reprints not available from the authors. |
Vol 86 - N° 1
P. 55-60 - janvier 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?